Literature DB >> 20400327

OX40 induces CCL20 expression in the context of antigen stimulation: an expanding role of co-stimulatory molecules in chemotaxis.

Wenwei Zhong1, Zili Zhang, David Hinrichs, Xiumei Wu, Mark Hall, Zhenwei Xia, James T Rosenbaum.   

Abstract

OX40 is an inducible co-stimulatory molecule expressed by activated T cells. It plays an important role in the activation and proliferation of T lymphocytes. Recently, some co-stimulatory molecules have been shown to direct leukocyte trafficking. Chemotaxis is essential for achieving an effective immune response. CCL20 is an important chemoattractant produced by activated T cells. In this study, using DO11.10 mice whose transgenic T cell receptor specifically recognizes ovalbumin, we demonstrate that ovalbumin induces OX40 expression in CD4+ lymphocytes. Further stimulation of OX40 by OX40 activating antibody up-regulates CCL20 production. Both NF-kappaB dependent and independent signaling pathways are implicated in the induction of CCL20 by OX40. Finally, we primed the DO11.10 splenocytes with or without OX40 activating antibody in the presence of ovalbumin. Intranasal administration of the cell lysates derived from the cells with OX40 stimulation results in more severe leukocyte infiltration in the lung of DO11.10 mice, which is substantially attenuated by CCL20 blocking antibody. Taken together, this study has shown that activation of OX40 induces CCL20 expression in the presence of antigen stimulation. Thus, our results broaden the role of OX40 in chemotaxis, and reveal a novel effect of co-stimulatory molecules in orchestrating both T cell up-regulation and migration. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20400327      PMCID: PMC2867600          DOI: 10.1016/j.cyto.2010.03.021

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  47 in total

1.  Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28.

Authors:  Vincenzo Mirenda; Sarah J Jarmin; Rachel David; Julian Dyson; Diane Scott; Yan Gu; Robert I Lechler; Klaus Okkenhaug; Federica M Marelli-Berg
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

2.  Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP-3alpha.

Authors:  R Varona; A Zaballos; J Gutiérrez; P Martín; F Roncal; J P Albar; C Ardavín; G Márquez
Journal:  FEBS Lett       Date:  1998-11-27       Impact factor: 4.124

3.  Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome.

Authors:  C Marie; C Fitting; C Cheval; M R Losser; J Carlet; D Payen; K Foster; J M Cavaillon
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Chemotactic migration triggers IL-8 generation in neutrophilic leukocytes.

Authors:  R A Siddiqui; L P Akard; J G Garcia; Y Cui; D English
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

Review 5.  Differentiation and functions of T cell subsets.

Authors:  T R Mosmann; L Li; H Hengartner; D Kagi; W Fu; S Sad
Journal:  Ciba Found Symp       Date:  1997

6.  Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-kappaB-dependent signaling pathway.

Authors:  Cheng-Yuan Kao; Fei Huang; Yin Chen; Philip Thai; Shinichiro Wachi; Christy Kim; Lucinda Tam; Reen Wu
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

Review 7.  Regulation of CD4 T cell memory by OX40 (CD134).

Authors:  Shahram Salek-Ardakani; Michael Croft
Journal:  Vaccine       Date:  2005-09-07       Impact factor: 3.641

8.  Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans.

Authors:  Y Tanaka; T Imai; M Baba; I Ishikawa; M Uehira; H Nomiyama; O Yoshie
Journal:  Eur J Immunol       Date:  1999-02       Impact factor: 5.532

9.  Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.

Authors:  A D Weinberg; K W Wegmann; C Funatake; R H Whitham
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

10.  CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1.

Authors:  S Flynn; K M Toellner; C Raykundalia; M Goodall; P Lane
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  4 in total

1.  15 kDa Granulysin versus GM-CSF for monocytes differentiation: analogies and differences at the transcriptome level.

Authors:  Luciano Castiello; David F Stroncek; Michael W Finn; Ena Wang; Francesco M Marincola; Carol Clayberger; Alan M Krensky; Marianna Sabatino
Journal:  J Transl Med       Date:  2011-04-18       Impact factor: 5.531

2.  Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness.

Authors:  Thomas W K Broughton; Mohamed A ElTanbouly; Evelien Schaafsma; Jie Deng; Aurélien Sarde; Walburga Croteau; Jiannan Li; Elizabeth C Nowak; Rodwell Mabaera; Nicole C Smits; Anna Kuta; Randolph J Noelle; J Louise Lines
Journal:  Front Immunol       Date:  2019-11-19       Impact factor: 8.786

3.  FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells.

Authors:  Lucia Campos Carrascosa; Adriaan A van Beek; Valeska de Ruiter; Michail Doukas; Jie Wei; Timothy S Fisher; Keith Ching; Wenjing Yang; Karlijn van Loon; Patrick P C Boor; Yannick S Rakké; Lisanne Noordam; Pascal Doornebosch; Dirk Grünhagen; Kees Verhoef; Wojciech G Polak; Jan N M IJzermans; Irene Ni; Yik Andy Yeung; Shahram Salek-Ardakani; Dave Sprengers; Jaap Kwekkeboom
Journal:  J Immunother Cancer       Date:  2020-09       Impact factor: 13.751

4.  Intraperitoneal administration of the anti-IL-23 antibody prevents the establishment of intestinal nematodes in mice.

Authors:  M Gomez-Samblas; D Bernal; A Bolado-Ortiz; S Vilchez; F Bolás-Fernández; A M Espino; M Trelis; A Osuna
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.